Coronavirus: Pfizer-BioNTech Covid-19 vaccine first to seek roll-out approval in Hong Kong

Jan 13, 2021 | INVESTING

The Pfizer-BioNTech Covid-19 vaccine developed by the US and Germany has become the first to apply for an emergency roll-out in Hong Kong and a government advisory panel is expected to decide as early as Monday whether to recommend its use amid confusion over the efficacy of the jab from China’s Sinovac.In an interview with the Post, experts on the panel would not jump to any conclusion on reports from Brazilian clinical trials that CoronaVac, developed by Sinovac, was just over 50 per cent…

Read More

Pin It on Pinterest